Found: 70
Select item for more details and to access through your institution.
Outcomes of Hepatic Artery-Based Therapies and Systemic Multiagent Chemotherapy in Unresectable Colorectal Liver Metastases: A Systematic Review and Meta-analysis.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 7, p. 4413, doi. 10.1245/s10434-024-15187-y
- By:
- Publication type:
- Article
Circulating Tumor DNA Predicts Early Recurrence Following Locoregional Therapy for Oligometastatic Colorectal Cancer.
- Published in:
- Cancers, 2024, v. 16, n. 13, p. 2407, doi. 10.3390/cancers16132407
- By:
- Publication type:
- Article
Outcome of Patients with Locally Advanced Rectal Cancer Pursuing Non-Surgical Strategy in National Cancer Database.
- Published in:
- Cancers, 2024, v. 16, n. 12, p. 2194, doi. 10.3390/cancers16122194
- By:
- Publication type:
- Article
Frequency of Common and Uncommon BRAF Alterations among Colorectal and Non-Colorectal Gastrointestinal Malignancies.
- Published in:
- Cancers, 2024, v. 16, n. 10, p. 1823, doi. 10.3390/cancers16101823
- By:
- Publication type:
- Article
Molecular Characterization and Therapeutic Opportunities in KRAS Wildtype Pancreatic Ductal Adenocarcinoma.
- Published in:
- Cancers, 2024, v. 16, n. 10, p. 1861, doi. 10.3390/cancers16101861
- By:
- Publication type:
- Article
Evaluating the Therapeutic Potential of Durvalumab in Adults with Locally Advanced or Metastatic Biliary Tract Cancer: Evidence to Date.
- Published in:
- OncoTargets & Therapy, 2024, v. 17, p. 383, doi. 10.2147/OTT.S391707
- By:
- Publication type:
- Article
Projected Incidence of Hepatobiliary Cancers and Trends Based on Age, Race, and Gender in the United States.
- Published in:
- Cancers, 2024, v. 16, n. 4, p. 684, doi. 10.3390/cancers16040684
- By:
- Publication type:
- Article
Adoption of Total Neoadjuvant Therapy in the Treatment of Locally Advanced Rectal Cancer.
- Published in:
- Current Oncology, 2024, v. 31, n. 1, p. 366, doi. 10.3390/curroncol31010024
- By:
- Publication type:
- Article
Long-term Survival in Patients with Advanced Hepatocellular Cancer with Dual Immunotherapy Agents: Tremelimumab Plus Durvalumab.
- Published in:
- touchREVIEWS in Oncology & Haematology, 2024, v. 20, n. 1, p. 2
- By:
- Publication type:
- Article
ASO Visual Abstact: NEO-GAP: A Single-Arm, Phase II Feasibility Trial of Neoadjuvant Gemcitabine, Cisplatin, and Nab-paclitaxel for Resectable, High-Risk Intrahepatic Cholangiocarcinoma.
- Published in:
- 2023
- By:
- Publication type:
- Abstract
Outcomes of Patients with Advanced Hepatocellular Carcinoma Receiving Lenvatinib following Immunotherapy: A Real World Evidence Study.
- Published in:
- Cancers, 2023, v. 15, n. 19, p. 4867, doi. 10.3390/cancers15194867
- By:
- Publication type:
- Article
Targeted Therapies in Advanced Cholangiocarcinoma.
- Published in:
- Life (2075-1729), 2023, v. 13, n. 10, p. 2066, doi. 10.3390/life13102066
- By:
- Publication type:
- Article
Phase II Trial of Trifluridine/Tipiracil Plus Irinotecan in Patients with Advanced, Refractory Biliary Tract Carcinoma.
- Published in:
- Oncologist, 2023, v. 28, n. 10, p. 917, doi. 10.1093/oncolo/oyad144
- By:
- Publication type:
- Article
ASO Visual Abstract: Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion for Pancreatic Cancer with Low-Volume Peritoneal Metastasis—Results from a Prospective Pilot Study.
- Published in:
- 2023
- By:
- Publication type:
- Abstract
Completion of Genetic Testing and Incidence of Pathogenic Germline Mutation among Patients with Early-Onset Colorectal Cancer: A Single Institution Analysis.
- Published in:
- Cancers, 2023, v. 15, n. 14, p. 3570, doi. 10.3390/cancers15143570
- By:
- Publication type:
- Article
Hypercalcemia of malignancy caused by parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumors (PTHrP-PNETs): Case Report.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1197288
- By:
- Publication type:
- Article
Analysis of Female Participant Representation in Registered Oncology Clinical Trials in the United States from 2008 to 2020.
- Published in:
- Oncologist, 2023, v. 28, n. 6, p. 510, doi. 10.1093/oncolo/oyad009
- By:
- Publication type:
- Article
Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion for Pancreatic Cancer with Low-Volume Peritoneal Metastasis: Results from a Prospective Pilot Study.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 1, p. 395, doi. 10.1245/s10434-022-12328-z
- By:
- Publication type:
- Article
Management of Appendix Neuroendocrine Neoplasms: Insights on the Current Guidelines.
- Published in:
- Cancers, 2023, v. 15, n. 1, p. 295, doi. 10.3390/cancers15010295
- By:
- Publication type:
- Article
Durvalumab: A PD-L1 Blocking Antibody for the Treatment of Adult Patients with Locally Advanced or Metastatic Biliary Tract Cancer.
- Published in:
- touchREVIEWS in Oncology & Haematology, 2023, v. 19, n. 1, p. 22, doi. 10.17925/OHR.2023.19.1.22
- By:
- Publication type:
- Article
Cabozantinib Following Immunotherapy in Patients with Advanced Hepatocellular Carcinoma.
- Published in:
- Cancers, 2022, v. 14, n. 21, p. 5173, doi. 10.3390/cancers14215173
- By:
- Publication type:
- Article
Outcomes following FGFR Inhibitor Therapy in Patients with Cholangiocarcinoma.
- Published in:
- 2022
- By:
- Publication type:
- journal article
FGFR2-IIIb Expression by Immunohistochemistry Has High Specificity in Cholangiocarcinoma with FGFR2 Genomic Alterations.
- Published in:
- Digestive Diseases & Sciences, 2022, v. 67, n. 8, p. 3797, doi. 10.1007/s10620-021-07303-9
- By:
- Publication type:
- Article
Analysis of Registered Clinical Trials in Gastroenterology, 2007-2019.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 7, p. e2221770, doi. 10.1001/jamanetworkopen.2022.21770
- By:
- Publication type:
- Article
Finding Waldo: The Evolving Paradigm of Circulating Tumor DNA (ctDNA)—Guided Minimal Residual Disease (MRD) Assessment in Colorectal Cancer (CRC).
- Published in:
- Cancers, 2022, v. 14, n. 13, p. N.PAG, doi. 10.3390/cancers14133078
- By:
- Publication type:
- Article
Analysis of Registered Clinical Trials in Gastroenterology, 2007-2019.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 7, p. 1, doi. 10.1001/jamanetworkopen.2022.21770
- By:
- Publication type:
- Article
First-Line Targeted Therapy for Hepatocellular Carcinoma: Role of Atezolizumab/Bevacizumab Combination.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Systemic Therapy of Metastatic Pancreatic Adenocarcinoma: Current Status, Challenges, and Opportunities.
- Published in:
- Cancers, 2022, v. 14, n. 11, p. 2588, doi. 10.3390/cancers14112588
- By:
- Publication type:
- Article
Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 3, p. 1579, doi. 10.1245/s10434-021-10991-2
- By:
- Publication type:
- Article
ASO Visual Abstract: Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer.
- Published in:
- 2022
- By:
- Publication type:
- Abstract
A pilot study of Pan-FGFR inhibitor ponatinib in patients with FGFR-altered advanced cholangiocarcinoma.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 1, p. 134, doi. 10.1007/s10637-021-01170-x
- By:
- Publication type:
- Article
Analysis of Registered Clinical Trials in Surgical Oncology, 2008-2020.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 1, p. e2145511, doi. 10.1001/jamanetworkopen.2021.45511
- By:
- Publication type:
- Article
Targeted Therapy for Advanced or Metastatic Cholangiocarcinoma: Focus on the Clinical Potential of Infigratinib.
- Published in:
- OncoTargets & Therapy, 2021, v. 14, p. 5145, doi. 10.2147/OTT.S272208
- By:
- Publication type:
- Article
Phase IB study of sorafenib and evofosfamide in patients with advanced hepatocellular and renal cell carcinomas (NCCTG N1135, Alliance).
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 4, p. 1072, doi. 10.1007/s10637-021-01090-w
- By:
- Publication type:
- Article
FGFR Inhibitors in Oncology: Insight on the Management of Toxicities in Clinical Practice.
- Published in:
- Cancers, 2021, v. 13, n. 12, p. 2968, doi. 10.3390/cancers13122968
- By:
- Publication type:
- Article
Predicting Adverse Pathologic Features and Clinical Outcomes of Resectable Pancreas Cancer With Preoperative CA 19-9.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.651119
- By:
- Publication type:
- Article
Aspirin and Statin Use and the Risk of Gallbladder Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 5, p. 1186, doi. 10.3390/cancers13051186
- By:
- Publication type:
- Article
Metastatic Colon Cancer Presenting With Immune-mediated Necrotizing Myopathy.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Research Progress of Biliary Tract Cancers.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
A Phase I Trial of Trametinib in Combination with Sorafenib in Patients with Advanced Hepatocellular Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e1893, doi. 10.1634/theoncologist.2020-0759
- By:
- Publication type:
- Article
Role of Surgery and Perioperative Therapy in Older Patients with Resectable Pancreatic Ductal Adenocarcinoma.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. e1681, doi. 10.1634/theoncologist.2020-0086
- By:
- Publication type:
- Article
The Promise of Circulating Tumor DNA (ctDNA) in the Management of Early-Stage Colon Cancer: A Critical Review.
- Published in:
- Cancers, 2020, v. 12, n. 10, p. 2808, doi. 10.3390/cancers12102808
- By:
- Publication type:
- Article
Targeted Therapies in Advanced Biliary Tract Cancer: An Evolving Paradigm.
- Published in:
- Cancers, 2020, v. 12, n. 8, p. 2039, doi. 10.3390/cancers12082039
- By:
- Publication type:
- Article
Phase II Trial of Trifluridine/Tipiracil in Patients with Advanced, Refractory Biliary Tract Carcinoma.
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. 380, doi. 10.1634/theoncologist.2019-0874
- By:
- Publication type:
- Article
First-In-Human Phase I Study Of A Dual mTOR Kinase And DNA-PK Inhibitor (CC-115) In Advanced Malignancy.
- Published in:
- Cancer Management & Research, 2019, v. 11, p. 10463, doi. 10.2147/CMAR.S208720
- By:
- Publication type:
- Article
Evaluating the Safety and Efficacy of Nivolumab in Patients with Advanced Hepatocellular Carcinoma: Evidence to Date.
- Published in:
- OncoTargets & Therapy, 2019, v. 12, p. 10335, doi. 10.2147/OTT.S214870
- By:
- Publication type:
- Article
A phase 2 study of an oral mTORC1/mTORC2 kinase inhibitor (CC-223) for non-pancreatic neuroendocrine tumors with or without carcinoid symptoms.
- Published in:
- PLoS ONE, 2019, v. 14, n. 9, p. 1, doi. 10.1371/journal.pone.0221994
- By:
- Publication type:
- Article
Novel Prognostic Factors in Resected Small Bowel Adenocarcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Immunotherapy in Hepatocellular Carcinoma: Is There a Light at the End of the Tunnel?
- Published in:
- Cancers, 2019, v. 11, n. 8, p. 1078, doi. 10.3390/cancers11081078
- By:
- Publication type:
- Article
First-in-human phase 1 dose-escalating trial of G305 in patients with advanced solid tumors expressing NY-ESO-1.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 7, p. 1211, doi. 10.1007/s00262-019-02331-x
- By:
- Publication type:
- Article